Agios Pharmaceuticals (AGIO) Capital Expenditures Growth (1y) (2013 - 2026)
Agios Pharmaceuticals (AGIO) Capital Expenditures Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,290.43 Bn | 66,290.15 Bn | - | 38.18% |
| 2 | Nanobiotix | 1,914.07 Bn | 1,914.01 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 4 | BeOne Medicines | 467.97 Bn | 463.18 Bn | 1.35 Bn | -27.93% |
| 5 | Vertex Pharmaceuticals | 122.73 Bn | 115.48 Bn | 2.59 Bn | 227.76% |
| 6 | Regeneron Pharmaceuticals | 70.42 Bn | 61.67 Bn | 3.31 Bn | 0.57% |
| 7 | Belite Bio | 62.82 Bn | 62.82 Bn | - | - |
| 8 | Argenx Se | 56.00 Bn | 50.82 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.51 Bn | 34.50 Bn | 959.66 Mn | 143.40% |
| 10 | Agios Pharmaceuticals | 2.23 Bn | 1.49 Bn | 19.43 Mn | 0.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.39% |
| Dec 31, 2025 | -103.26% |
| Sep 30, 2025 | -6,968.42% |
| Jun 30, 2025 | 1,983.33% |
| Dec 31, 2024 | 64.87% |
| Sep 30, 2024 | 137.50% |
| Jun 30, 2024 | 110.69% |
| Dec 31, 2023 | 121.37% |
| Sep 30, 2023 | -99.83% |
| Jun 30, 2023 | 85.93% |
| Mar 31, 2023 | -85.77% |
| Dec 31, 2022 | -202.40% |
| Sep 30, 2022 | 302.11% |
| Jun 30, 2022 | -192.15% |
| Mar 31, 2022 | 177.08% |
| Dec 31, 2021 | 134.42% |
| Sep 30, 2021 | -88.08% |
| Jun 30, 2021 | 47.56% |
| Mar 31, 2021 | -81.41% |
| Dec 31, 2020 | -7,206.70% |